TNF Inhibitors Market By Drug, Application and Distribution Channel - Global Industry Analysis And Forecast To 2027
Published On : January 2019 Pages : 150 Category: Petrochemicals Report Code : CM012251
TNF Inhibitors Market By Drug (Infliximab, Golimumab, Adalimumab, Etanercept and Certolizumab), Application (Ankylosing Spondylitis, Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriasis and Other Applications) and Distribution Channel (Online Pharmacy, Hospital Pharmacy and Retail Pharmacy) - Global Industry Analysis And Forecast To 2027
Industry Outlook
TNF is abbreviated as Tumor Necrosis Factor. TNF Inhibitors are medications that are used for stopping inflammation; they are used in diseases like juvenile arthritis, plaque psoriasis, rheumatoid arthritis (RA), psoriatic arthritis, ulcerative colitis (UC), Crohn's disease and ankylosing spondylitis. TNF Inhibitors are antibodies that are developed in lab from tissues of both animals & humans. After being injected in the blood they cause reaction in immune system that helps in blocking inflammation. The use of TNF Inhibitors is increasing due to; growing number of aged population across the globe, rising preference amongst the patients, increasing number of cases related to rheumatic diseases, etc. Therefore, the TNF Inhibitors Market is anticipated to expand and has tremendous scope during the forecast period. The global TNF Inhibitors Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global TNF Inhibitors Market is based on segment, by Drug the market is segmented into Infliximab, Golimumab, Adalimumab, Etanercept and Certolizumab, by Application the market is segmented into Ankylosing Spondylitis, Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriasis and Other Applications, and by Distribution Channel the market is segmented into Online Pharmacy, Hospital Pharmacy and Retail Pharmacy.
- TNF Inhibitors Market, By Drug
- Infliximab
- Golimumab
- Adalimumab
- Etanercept
- Certolizumab
- TNF Inhibitors Market, By Application
- Ankylosing Spondylitis
- Inflammatory Bowel Disease
- Rheumatoid Arthritis
- Psoriasis
- Other Applications
- TNF Inhibitors Market, By Distribution Channel
- Online Pharmacy
- Hospital Pharmacy
- Retail Pharmacy
Regional Insights
On a global front, the TNF Inhibitors Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). European region is dominating the TNF Inhibitors Market followed by North American region owing to; large number of aged population suffering from inflammatory conditions in the region.
TNF Inhibitors Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Pfizer Inc., Takeda Pharmaceutical Company, Samsung Bioepis, AbbVie Inc., Merck & Co., Janssen Biotech Inc., Biogen, UCB and Amgen Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Pfizer Inc.
- Takeda Pharmaceutical Company
- Samsung Bioepis
- AbbVie Inc.
- Merck & Co.
- Janssen Biotech Inc.
- Biogen
- UCB
- Amgen Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· TNF Inhibitors Market, By Drug, Estimates and Forecast, 2017-2027 ($Million)
o Infliximab
o Golimumab
o Adalimumab
o Etanercept
o Certolizumab
· TNF Inhibitors Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Ankylosing Spondylitis
o Inflammatory Bowel Disease
o Rheumatoid Arthritis
o Psoriasis
o Other Applications
· TNF Inhibitors Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Online Pharmacy
o Hospital Pharmacy
o Retail Pharmacy
· TNF Inhibitors Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America TNF Inhibitors Market, By Country
o U.S. TNF Inhibitors Market
o Canada TNF Inhibitors Market
o Mexico TNF Inhibitors Market
o Europe
§ Europe TNF Inhibitors Market, By Country
o Germany TNF Inhibitors Market
o UK TNF Inhibitors Market
o France TNF Inhibitors Market
o Russia TNF Inhibitors Market
o Italy TNF Inhibitors Market
o Rest of Europe TNF Inhibitors Market
o Asia-Pacific
§ Asia-Pacific TNF Inhibitors Market, By Country
o China TNF Inhibitors Market
o Japan TNF Inhibitors Market
o South Korea TNF Inhibitors Market
o India TNF Inhibitors Market
o Southeast Asia TNF Inhibitors Market
o Rest of Asia-Pacific TNF Inhibitors Market
o South America
§ South America TNF Inhibitors Market, By Country
o Brazil TNF Inhibitors Market
o Argentina TNF Inhibitors Market
o Columbia TNF Inhibitors Market
o Rest of South America TNF Inhibitors Market
o Middle East and Africa
§ Middle East and Africa TNF Inhibitors Market, By Country
o Saudi Arabia TNF Inhibitors Market
o UAE TNF Inhibitors Market
o Egypt TNF Inhibitors Market
o Nigeria TNF Inhibitors Market
o South Africa TNF Inhibitors Market
o Rest of MEA TNF Inhibitors Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. TNF Inhibitors Market, By Drug
5.1. Introduction
5.2. Global TNF Inhibitors Revenue and Market Share by Drug (2017-2027)
5.2.1. Global TNF Inhibitors Revenue and Revenue Share by Drug (2017-2027)
5.3. Infliximab
5.3.1. Global Infliximab Revenue and Growth Rate (2017-2027)
5.4. Golimumab
5.4.1. Global Golimumab Revenue and Growth Rate (2017-2027)
5.5. Adalimumab
5.5.1. Global Adalimumab Revenue and Growth Rate (2017-2027)
5.6. Etanercept
5.6.1. Global Etanercept Revenue and Growth Rate (2017-2027)
5.7. Certolizumab
5.7.1. Global Certolizumab Revenue and Growth Rate (2017-2027)
6. TNF Inhibitors Market, By Application
6.1. Introduction
6.2. Global TNF Inhibitors Revenue and Market Share by Application (2017-2027)
6.2.1. Global TNF Inhibitors Revenue and Revenue Share by Application (2017-2027)
6.3. Ankylosing Spondylitis
6.3.1. Global Ankylosing Spondylitis Revenue and Growth Rate (2017-2027)
6.4. Inflammatory Bowel Disease
6.4.1. Global Inflammatory Bowel Disease Revenue and Growth Rate (2017-2027)
6.5. Rheumatoid Arthritis
6.5.1. Global Rheumatoid Arthritis Revenue and Growth Rate (2017-2027)
6.6. Psoriasis
6.6.1. Global Psoriasis Revenue and Growth Rate (2017-2027)
6.7. Other Applications
6.7.1. Global Other Applications Revenue and Growth Rate (2017-2027)
7. TNF Inhibitors Market, By Distribution Channel
7.1. Introduction
7.2. Global TNF Inhibitors Revenue and Market Share by Distribution Channel (2017-2027)
7.2.1. Global TNF Inhibitors Revenue and Revenue Share by Distribution Channel (2017-2027)
7.3. Online Pharmacy
7.3.1. Global Online Pharmacy Revenue and Growth Rate (2017-2027)
7.4. Hospital Pharmacy
7.4.1. Global Hospital Pharmacy Revenue and Growth Rate (2017-2027)
7.5. Retail Pharmacy
7.5.1. Global Retail Pharmacy Revenue and Growth Rate (2017-2027)
8. TNF Inhibitors Market, By Region
8.1. Introduction
8.2. Global TNF Inhibitors Revenue and Market Share by Regions
8.2.1. Global TNF Inhibitors Revenue by Regions (2017-2027)
8.3. North America TNF Inhibitors by Countries
8.3.1. North America TNF Inhibitors Revenue and Growth Rate (2017-2027)
8.3.2. North America TNF Inhibitors Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe TNF Inhibitors by Countries
8.4.1. Europe TNF Inhibitors Revenue and Growth Rate (2017-2027)
8.4.2. Europe TNF Inhibitors Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific TNF Inhibitors by Countries
8.5.1. Asia-Pacific TNF Inhibitors Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific TNF Inhibitors Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America TNF Inhibitors by Countries
8.6.1. South America TNF Inhibitors Revenue and Growth Rate (2017-2027)
8.6.2. South America TNF Inhibitors Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa TNF Inhibitors by Countries
8.7.1. Middle East and Africa TNF Inhibitors Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa TNF Inhibitors Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Pfizer Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Takeda Pharmaceutical Company
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Samsung Bioepis
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. AbbVie Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Merck & Co.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Janssen Biotech Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Biogen
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. UCB
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Amgen Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
10. Global TNF Inhibitors Market Competition, by Manufacturer
10.1. Global TNF Inhibitors Revenue and Market Share by Manufacturer (2017-2017)
10.2. Top 5 TNF Inhibitors Manufacturer Market Share
10.3. Market Competition Trend
11. TNF Inhibitors Market Forecast (2017-2027)
11.1. Global TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. TNF Inhibitors Market Forecast by Regions (2017-2027)
11.2.1. North America TNF Inhibitors Market Forecast (2017-2027)
11.2.1.1. United States TNF Inhibitors Market Forecast (2017-2027)
11.2.1.2. Canada TNF Inhibitors Market Forecast (2017-2027)
11.2.1.3. Mexico TNF Inhibitors Market Forecast (2017-2027)
11.2.2. Europe TNF Inhibitors Market Forecast (2017-2027)
11.2.2.1. Germany TNF Inhibitors Market Forecast (2017-2027)
11.2.2.2. France TNF Inhibitors Market Forecast (2017-2027)
11.2.2.3. UK TNF Inhibitors Market Forecast (2017-2027)
11.2.2.4. Russia TNF Inhibitors Market Forecast (2017-2027)
11.2.2.5. Italy TNF Inhibitors Market Forecast (2017-2027)
11.2.2.6. Rest of Europe TNF Inhibitors Market Forecast (2017-2027)
11.2.3. Asia-Pacific TNF Inhibitors Market Forecast (2017-2027)
11.2.3.1. China TNF Inhibitors Market Forecast (2017-2027)
11.2.3.2. Japan TNF Inhibitors Market Forecast (2017-2027)
11.2.3.3. Korea TNF Inhibitors Market Forecast (2017-2027)
11.2.3.4. India TNF Inhibitors Market Forecast (2017-2027)
11.2.3.5. Southeast Asia TNF Inhibitors Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific TNF Inhibitors Market Forecast (2017-2027)
11.2.4. South America TNF Inhibitors Market Forecast (2017-2027)
11.2.4.1. Brazil TNF Inhibitors Market Forecast (2017-2027)
11.2.4.2. Argentina TNF Inhibitors Market Forecast (2017-2027)
11.2.4.3. Columbia TNF Inhibitors Market Forecast (2017-2027)
11.2.4.4. Rest of South America TNF Inhibitors Market Forecast (2017-2027)
11.2.5. Middle East and Africa TNF Inhibitors Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia TNF Inhibitors Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates TNF Inhibitors Market Forecast (2017-2027)
11.2.5.3. Egypt TNF Inhibitors Market Forecast (2017-2027)
11.2.5.4. Nigeria TNF Inhibitors Market Forecast (2017-2027)
11.2.5.5. South Africa TNF Inhibitors Market Forecast (2017-2027)
11.2.5.6. Turkey TNF Inhibitors Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa TNF Inhibitors Market Forecast (2017-2027)
11.3. TNF Inhibitors Market Forecast by Drug (2017-2027)
11.3.1. TNF Inhibitors Forecast by Drug (2017-2027)
11.3.2. TNF Inhibitors Market Share Forecast by Drug (2017-2027)
11.4. TNF Inhibitors Market Forecast by Application (2017-2027)
11.4.1. TNF Inhibitors Forecast by Application (2017-2027)
11.4.2. TNF Inhibitors Market Share Forecast by Application (2017-2027)
11.5. TNF Inhibitors Market Forecast by Distribution Channel (2017-2027)
11.5.1. TNF Inhibitors Forecast by Distribution Channel (2017-2027)
11.5.2. TNF Inhibitors Market Share Forecast by Distribution Channel (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure France TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure China TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure India TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa TNF Inhibitors Revenue (Million USD) and Growth Rate (2017-2025)
Table Global TNF Inhibitors Revenue and Revenue Share by Drug (2017-2018)
Figure Global Infliximab Revenue and Growth Rate (2017-2018)
Figure Global Golimumab Revenue and Growth Rate (2017-2018)
Figure Global Adalimumab Revenue and Growth Rate (2017-2018)
Figure Global Etanercept Revenue and Growth Rate (2017-2018)
Figure Global Certolizumab Revenue and Growth Rate (2017-2018)
Table Global TNF Inhibitors Revenue and Revenue Share by Application (2017-2018)
Figure Global Ankylosing Spondylitis Revenue and Growth Rate (2017-2018)
Figure Global Inflammatory Bowel Disease Revenue and Growth Rate (2017-2018)
Figure Global Rheumatoid Arthritis Revenue and Growth Rate (2017-2018)
Figure Global Psoriasis Revenue and Growth Rate (2017-2018)
Figure Global Other Applications Revenue and Growth Rate (2017-2018)
Table Global TNF Inhibitors Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Online Pharmacy Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacy Revenue and Growth Rate (2017-2018)
Figure Global Retail Pharmacy Revenue and Growth Rate (2017-2018)
Table Global TNF Inhibitors Revenue by Regions (2017-2018)
Figure North America TNF Inhibitors Growth Rate (2017-2018)
Figure North America TNF Inhibitors Revenue and Growth Rate (2017-2018)
Figure North America TNF Inhibitors by Countries (2017-2018)
Figure North America TNF Inhibitors Revenue (Million USD) by Countries (2017-2018)
Figure United States TNF Inhibitors Growth Rate (2017-2018)
Figure United States TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada TNF Inhibitors Growth Rate (2017-2018)
Figure Canada TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico TNF Inhibitors Growth Rate (2017-2018)
Figure Mexico TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe TNF Inhibitors Growth Rate (2017-2018)
Figure Europe TNF Inhibitors Revenue and Growth Rate (2017-2018)
Figure Europe TNF Inhibitors by Countries (2017-2018)
Figure Europe TNF Inhibitors Revenue (Million USD) by Countries (2017-2018)
Figure Germany TNF Inhibitors Growth Rate (2017-2018)
Figure Germany TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France TNF Inhibitors Growth Rate (2017-2018)
Figure France TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK TNF Inhibitors Growth Rate (2017-2018)
Figure UK TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia TNF Inhibitors Growth Rate (2017-2018)
Figure Russia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy TNF Inhibitors Growth Rate (2017-2018)
Figure Italy TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe TNF Inhibitors Growth Rate (2017-2018)
Figure Rest of Europe TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific TNF Inhibitors Growth Rate (2017-2018)
Figure Asia-Pacific TNF Inhibitors Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific TNF Inhibitors by Countries (2017-2018)
Figure Asia-Pacific TNF Inhibitors Revenue (Million USD) by Countries (2017-2018)
Figure China TNF Inhibitors Growth Rate (2017-2018)
Figure China TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan TNF Inhibitors Growth Rate (2017-2018)
Figure Japan TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea TNF Inhibitors Growth Rate (2017-2018)
Figure Korea TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India TNF Inhibitors Growth Rate (2017-2018)
Figure India TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia TNF Inhibitors Growth Rate (2017-2018)
Figure Southeast Asia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific TNF Inhibitors Growth Rate (2017-2018)
Figure Rest of Asia-Pacific TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America TNF Inhibitors Growth Rate (2017-2018)
Figure South America TNF Inhibitors Revenue and Growth Rate (2017-2018)
Figure South America TNF Inhibitors by Countries (2017-2018)
Figure South America TNF Inhibitors Revenue (Million USD) by Countries (2017-2018)
Figure Brazil TNF Inhibitors Growth Rate (2017-2018)
Figure Brazil TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina TNF Inhibitors Growth Rate (2017-2018)
Figure Argentina TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia TNF Inhibitors Growth Rate (2017-2018)
Figure Columbia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America TNF Inhibitors Growth Rate (2017-2018)
Figure Rest of South America TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa TNF Inhibitors Growth Rate (2017-2018)
Figure Middle East and Africa TNF Inhibitors Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa TNF Inhibitors by Countries (2017-2018)
Figure Middle East and Africa TNF Inhibitors Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia TNF Inhibitors Growth Rate (2017-2018)
Figure Saudi Arabia TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates TNF Inhibitors Growth Rate (2017-2018)
Figure United Arab Emirates TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt TNF Inhibitors Growth Rate (2017-2018)
Figure Egypt TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria TNF Inhibitors Growth Rate (2017-2018)
Figure Nigeria TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa TNF Inhibitors Growth Rate (2017-2018)
Figure South Africa TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey TNF Inhibitors Growth Rate (2017-2018)
Figure Turkey TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa TNF Inhibitors Growth Rate (2017-2018)
Figure Rest of Middle East and Africa TNF Inhibitors Revenue (Millions USD) and Growth Rate (2017-2018)
Table Pfizer Inc. TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Takeda Pharmaceutical Company TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Samsung Bioepis TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AbbVie Inc. TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co. TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Janssen Biotech Inc. TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Biogen TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table UCB TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Amgen Inc. TNF Inhibitors Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global TNF Inhibitors Market Share by Manufacturer
Figure Global TNF Inhibitors Revenue and Market Share by Manufacturer
Table Global TNF Inhibitors Price by Region (2017-2017)
Figure Top 5 TNF Inhibitors Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global TNF Inhibitors Revenue (Millions USD) and Growth Rate (2018-2025)
Table TNF Inhibitors Market Forecast by Regions (2018-2025)
Figure North America TNF Inhibitors Market Forecast (2018-2025)
Figure United States TNF Inhibitors Market Forecast (2018-2025)
Figure Canada TNF Inhibitors Market Forecast (2018-2025)
Figure Mexico TNF Inhibitors Market Forecast (2018-2025)
Figure Europe TNF Inhibitors Market Forecast (2018-2025)
Figure Germany TNF Inhibitors Market Forecast (2018-2025)
Figure France TNF Inhibitors Market Forecast (2018-2025)
Figure UK TNF Inhibitors Market Forecast (2018-2025)
Figure Russia TNF Inhibitors Market Forecast (2018-2025)
Figure Italy TNF Inhibitors Market Forecast (2018-2025)
Figure Rest of Europe TNF Inhibitors Market Forecast (2018-2025)
Figure Asia-Pacific TNF Inhibitors Market Forecast (2018-2025)
Figure China TNF Inhibitors Market Forecast (2018-2025)
Figure Japan TNF Inhibitors Market Forecast (2018-2025)
Figure Korea TNF Inhibitors Market Forecast (2018-2025)
Figure India TNF Inhibitors Market Forecast (2018-2025)
Figure Southeast Asia TNF Inhibitors Market Forecast (2018-2025)
Figure Rest of Asia-Pacific TNF Inhibitors Market Forecast (2018-2025)
Figure South America TNF Inhibitors Market Forecast (2018-2025)
Figure Brazil TNF Inhibitors Market Forecast (2018-2025)
Figure Argentina TNF Inhibitors Market Forecast (2018-2025)
Figure Columbia TNF Inhibitors Market Forecast (2018-2025)
Figure Rest of South America TNF Inhibitors Market Forecast (2018-2025)
Figure Middle East and Africa TNF Inhibitors Market Forecast (2018-2025)
Figure Saudi Arabia TNF Inhibitors Market Forecast (2018-2025)
Figure United Arab Emirates TNF Inhibitors Market Forecast (2018-2025)
Figure Egypt TNF Inhibitors Market Forecast (2018-2025)
Figure Nigeria TNF Inhibitors Market Forecast (2018-2025)
Figure South Africa TNF Inhibitors Market Forecast (2018-2025)
Figure Turkey TNF Inhibitors Market Forecast (2018-2025)
Figure Rest of Middle East and Africa TNF Inhibitors Market Forecast (2018-2025)
Figure Global TNF Inhibitors Forecast by Drug (2018-2025)
Figure Global TNF Inhibitors Market Share Forecast by Drug (2018-2025)
Figure Global TNF Inhibitors Forecast by Drug (2018-2025)
Figure Global TNF Inhibitors Forecast by Application (2018-2025)
Figure Global TNF Inhibitors Market Share Forecast by Application (2018-2025)
Figure Global TNF Inhibitors Forecast by Application (2018-2025)
Figure Global TNF Inhibitors Forecast by Distribution Channel (2018-2025)
Figure Global TNF Inhibitors Market Share Forecast by Distribution Channel (2018-2025)
Figure Global TNF Inhibitors Forecast by Distribution Channel (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|